SCHEMBL5887724

SCHEMBL5887724

COc1ccncc1C1=C(c2ccc(Cl)cc2)C=CC[CH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.41
GCGR P47871 1/20 0.38
MAPK14 Q16539 1/20 0.38
PTGS1 P23219 1/20 0.37
PTGS2 P35354 1/20 0.37
ABL1 P00519 2/20 0.36
NAAA Q02083 1/20 0.35
MEN1 O00255 1/20 0.35
HPGD P15428 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
POLQ O75417 1/20 0.35
CYP1A2 P05177 2/20 0.34
CYP2E1 P05181 2/20 0.34
CYP2D6 P10635 2/20 0.34
CYP2A6 P11509 2/20 0.34
CYP2B6 P20813 2/20 0.34
CYP2C19 P33261 2/20 0.34
SLC6A2 P23975 2/20 0.34
SLC6A4 P31645 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5049092 0.77 GSK3B (0.49) GSK3BGCGRMAPK14PTGS1PTGS2
SCHEMBL6047592 0.75 ALOX5 (0.44) GSK3BMEN1HPGDKMT2ASMN1; SMN2
SCHEMBL27718711 0.70 GCGR (0.44) GSK3BGCGRMAPK14MEN1HPGD
SCHEMBL6627488 0.68 KDM4E (0.61) SMN1; SMN2CYP1A2CYP2E1CYP2D6CYP2A6
SCHEMBL22230061 0.66 PDE10A (0.51) GSK3BPTGS1PTGS2ABL1NAAA
SCHEMBL12864158 0.65 NAAA (0.47) PTGS1PTGS2ABL1NAAACYP1A2
SCHEMBL21180023 0.64 ERN1 (0.44) PTGS1PTGS2ABL1NAAASMN1; SMN2
SCHEMBL6291800 0.64 NAAA (0.46) GSK3BPTGS1PTGS2ABL1NAAA
SCHEMBL27892826 0.64 CYP1A2 (0.51) GCGRMAPK14PTGS1PTGS2NAAA
SCHEMBL2247267 0.64 HDAC6 (0.63) PTGS2HPGDSMN1; SMN2CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7037931-B2 Corticotropin releasing factor moderator; analgesics; drug abruse, drug dependency; schizophrenia JANSSEN PHARMACEUTICA N.V. (BE) 2006-05-02 US claimed
JP-2006501194-A 2006-01-12 JP claimed
EP-1525190-A1 CCK-1 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-04-27 EP claimed
WO-2004007463-A1 CCK-1 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2004-01-22 WO claimed